Personalized participatory medicine: sharing knowledge and uncertainty

被引：0
|
作者：
David Gurwitz
Jeantine E Lunshof
机构：
[1] Sackler Faculty of Medicine,Department of Human Molecular Genetics and Biochemistry
[2] Tel-Aviv University,Faculty of Health, Medicine and Life Sciences
[3] Maastricht University,Department of Molecular Cell Physiology, Faculty of Earth and Life Sciences
[4] VU University Amsterdam and Netherlands Institute for Systems Biology (NISB),Ethics Consultant, Center for Excellence in Genomic Science and Personal Genome Project, Department of Genetics
[5] Harvard Medical School,undefined
来源：
Genome Medicine | / 3卷
关键词：
Tamoxifen; Personalized Medicine; Breast Cancer Recurrence; Alternative Treatment Option; Personal Genome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Informing patients about risks and benefits of alternative treatment options and choosing between them is becoming a bigger challenge as knowledge about the relationship between the individual's genetic profile and the efficacy and safety of available medications accumulates. Putting personalized medicine into practice requires new modes of information sharing and decision making by patient and physician. This is illustrated by a case study on treatment choices of breast cancer patients following genotyping for CYP2D6, recently published in Genome Medicine.
引用
收藏
相关论文
共 50 条
  • [1] Personalized participatory medicine: sharing knowledge and uncertainty
    Gurwitz, David
    Lunshof, Jeantine E.
    [J]. GENOME MEDICINE, 2011, 3
  • [2] Pharmacogenomics Knowledge for Personalized Medicine
    Klein, T.
    Ritchie, M.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 30 - 31
  • [3] Pharmacogenomics Knowledge for Personalized Medicine
    Whirl-Carrillo, M.
    McDonagh, E. M.
    Hebert, J. M.
    Gong, L.
    Sangkuhl, K.
    Thorn, C. F.
    Altman, R. B.
    Klein, T. E.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (04) : 414 - 417
  • [4] Pharmacogenomics knowledge for personalized medicine
    Whirl-Carrillo, Michelle
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 89 - 89
  • [5] Merging Personalized and Participatory Medicine: Interpretation of Individual Genomes
    Koutsoukis, Alexander J.
    Lopez-Campos, Guillermo H.
    Martin-Sanchez, Fernando
    [J]. INTEGRATING INFORMATION TECHNOLOGY AND MANAGEMENT FOR QUALITY OF CARE, 2014, 202 : 24 - 27
  • [6] Psoriasis in the perspective of predictive, preventive participatory and personalized medicine
    van de Kerkhof, Peter C. M.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (02) : 107 - 108
  • [7] Predictive, preventive, personalized and participatory medicine: back to the future
    Auffray, Charles
    Charron, Dominique
    Hood, Leroy
    [J]. GENOME MEDICINE, 2010, 2
  • [8] Predictive, preventive, personalized and participatory medicine: back to the future
    Charles Auffray
    Dominique Charron
    Leroy Hood
    [J]. Genome Medicine, 2
  • [9] Systems pharmacology meets predictive, preventive, personalized and participatory medicine
    Jenkins, Sherry L.
    Ma'ayan, Avi
    [J]. PHARMACOGENOMICS, 2013, 14 (02) : 119 - 122
  • [10] Discovering, visualizing, and sharing knowledge through personalized learning knowledge maps
    Novak, J
    Wurst, M
    Fleischmann, M
    Strauss, W
    [J]. AGENT-MEDIATED KNOWLEDGE MANAGEMENT, 2004, 2926 : 213 - 228
12345